Rockwell Medical (RMTI) Prices 11.5M Common Stock Offering

Rockwell Medical, Inc. (Nasdaq: RMTI) has priced an underwritten public offering of 11,475,410 shares of its common stock at a price to the public of $3.05 per share for gross proceeds of $35.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Rockwell, will be approximately $32.8 million. Rockwell has also granted the underwriters a 30-day option to purchase up to an additional 1,721,312 shares of common stock offered in the public offering to cover overallotments, if any.

The net proceeds of the offering will be used to fund SFP clinical trials and for other general corporate purposes. The offering is expected to close on or about May 20, 2013, subject to the satisfaction of customary closing conditions.

Chardan Capital Markets, LLC is acting as the sole book-running manager for the offering. Summer Street Research Partners is acting as lead manager for the offering. C&Co/Prince Ridge LLC is acting as co-manager for the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• DeFi Development Corp. plans $20M preferred stock offering
• Lobe Sciences closes $2.16M private placement for S-100 drug program
• TXNM Energy launches $400M common stock offering